This limited competition funds continued operation of National Cancer Institute biospecimen banks supporting national, early-phase, and experimental cancer clinical trials and translational research.
NCI supports research on how biospecimen collection, processing, and storage affect biomarkers, aiming to standardize handling and improve clinical assay development; clinical trials are not allowed.
NIH supports national biomedical imaging and bioengineering centers that develop research-driven technologies, share them with investigators, and train researchers in their use.
This grant funds national biomedical research centers to develop innovative human-based research models and technologies that reduce animal use, supporting advanced science and national security across multiple NIH institutes.
NIH's limited competition supports expansion and sustainability of biomedical research centers at eligible institutions in states with historically low NIH funding; clinical trials are not allowed.
This grant funds a national research network to study how cancer and normal tissues respond biologically to radiation therapy, aiming to improve treatment and discover new therapy opportunities.